RecruitingNCT06145100
Prediction of Portal Hypertension in Patients With CVID (CVID-pHT)
Studying Non-malignant and non-cirrhotic portal vein thrombosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University Hospital Freiburg
- Principal Investigator
- Dominik Bettinger, MDUniversity Hospital Freiburg
- Intervention
- Ultrasound including color doppler ultrasound(diagnostic_test)
- Enrollment
- 250 target
- Eligibility
- 18 years · All sexes
- Timeline
- 2023 – 2025
Study locations (1)
- University Medical Center Freiburg, Department of Medicine II, Freiburg im Breisgau, Germany
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06145100 on ClinicalTrials.govOther trials for Non-malignant and non-cirrhotic portal vein thrombosis
Additional recruiting or active studies for the same condition.
See all trials for Non-malignant and non-cirrhotic portal vein thrombosis →